Scilex to present on ZTlido at 2024 Annual PAINWeek Conference

Scilex Holding Company announced oral, poster presentations, and symposia on ZTlido at the 2024 Annual PAINWeek conference in Las Vegas, NV on September 3-5, 2024. Key highlights of the ZTlido 1.8% presentation: September 4, 2024; NON-CME Presentation in the Castellana Ballroom. 12:00PM PT – 1:00PM PT; TITLE: What to do when pain relief with Gabapentinoids isn’t enough? DESCRIPTION: Gabapentinoids are the foundational analgesics used to treat neuropathic pain of PHN, and their usage has grown rapidly in recent years given increasing scrutiny around opioid prescribing. The unmet need, though, remains high, given the challenges with titrating them to an effective dose. Dr Charles Argoff will review what analgesic options exist to optimize gabapentinoids, and the trade-offs that come with different agents. Dr. Argoff is Professor of Neurology and Director of the Comprehensive Pain Program at Albany Medical Center in New York. He is an internationally renowned for his work in Pain Management – in research, teaching and patient care, and serves as the President of AAPM/ September 5, 2024: 5:50PM PT – 6:00PM PT: Decreased Opioid Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis to be Presented by Srinivas Nalamachu, M.D. 6:05PM PT – 6:15PM PT: Decreased Cost Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis to be Presented by Srinivas Nalamachu, M.D.